LUNG ADENOSQUAMOUS CARCINOMA
Clinical trials for LUNG ADENOSQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG ADENOSQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radiation boost may extend life for hard-to-treat lung cancer patients
Disease control TerminatedThis study looks at whether adding radiation therapy to standard immunotherapy (with or without chemotherapy) can help people with advanced non-small cell lung cancer that lacks the PD-L1 marker. About 427 adults with stage IIIB, IIIC, or IV disease will be randomly assigned to r…
Matched conditions: LUNG ADENOSQUAMOUS CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
New cocktail for inoperable lung cancer shows promise in early trial
Disease control OngoingThis study tested a three-part treatment for people with stage III lung cancer that cannot be removed by surgery. The treatment combined standard chemotherapy (cisplatin and etoposide) with radiation, followed by two additional drugs (docetaxel and bevacizumab) to try to kill mor…
Matched conditions: LUNG ADENOSQUAMOUS CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC